Skip to main content
. 2023 Jun 15;15(6):959–972. doi: 10.4251/wjgo.v15.i6.959

Figure 3.

Figure 3

The mechanisms of action of immune checkpoint inhibitors in cancer immunotherapy. CTLA-4: Cytotoxic T lymphocyte antigen 4; MHC: Major histocompatibility complex; PD-1: Programmed cell death protein 1; PD-L1: Programmed death-ligand 1; TCR: T cell receptor.